Kairos Pharma’s (KAPA) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note released on Thursday,Benzinga reports. D. Boral Capital currently has a $9.00 price target on the stock. Kairos Pharma Stock Up 3.1 % Kairos Pharma stock opened at $1.01 on Thursday. The firm has a 50 […]
D. Boral Capital reaffirmed their buy rating on shares of Kairos Pharma (NYSEAMERICAN:KAPA – Free Report) in a research note released on Thursday,Benzinga reports. D. Boral Capital currently has a $9.00 price target on the stock. Kairos Pharma Stock Up 3.1 % Kairos Pharma stock opened at $1.01 on Thursday. The firm has a 50 […]
